NIH Funding · FY2024
Total Funding
$2M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#5,516
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2M across 2 grants · National rank #5516.
Top grants by award amount
Sumana Chakravarty's NIH grant portfolio, ranked by award amount.
- 2U44AI124867-06U44Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$1Maward amount
- 5R44AI125009-06R44A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968.4Kaward amount
Affiliation
Institutions that have administered grants for Sumana Chakravarty.
Affiliated with Sanaria, Inc. (MD).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardSanaria, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5516
Related investigators
Other NIH-funded PIs frequently associated with Sumana Chakravarty.
Explore further
Find collaborators for Sumana Chakravarty
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Sanaria, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →